𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acceptability and clinical activity of 4 weeks' treatment by S12024-2 in 53 in-patients with moderate to severe Alzheimer's disease

✍ Scribed by Stefas, E.; Papastefanou, M.; Patrelis, A.; Tzanos, I.A.; Tziotzou, K.

Book ID
124117023
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
350 KB
Volume
15
Category
Article
ISSN
0197-4580

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tolerability of switching from donepezil
Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
✍ Gunhild Waldemar; Maritta HyvΓ€rinen; Mette Krog Josiassen; Alex KΓΈrner; Heikki L πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 44 KB πŸ‘ 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving